203 related articles for article (PubMed ID: 18509010)
1. Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin beta conjugate.
Vuorenoja S; Rivero-Müller A; Ziecik AJ; Huhtaniemi I; Toppari J; Rahman NA
Endocr Relat Cancer; 2008 Jun; 15(2):635-48. PubMed ID: 18509010
[TBL] [Abstract][Full Text] [Related]
2. Hecate-CGbeta conjugate and gonadotropin suppression shows two distinct mechanisms of action in the treatment of adrenocortical tumors in transgenic mice expressing Simian Virus 40 T antigen under inhibin-alpha promoter.
Vuorenoja S; Mohanty BP; Arola J; Huhtaniemi I; Toppari J; Rahman NA
Endocr Relat Cancer; 2009 Jun; 16(2):549-64. PubMed ID: 19261682
[TBL] [Abstract][Full Text] [Related]
3. A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice.
Bodek G; Vierre S; Rivero-Müller A; Huhtaniemi I; Ziecik AJ; Rahman NA
Neoplasia; 2005 May; 7(5):497-508. PubMed ID: 15967102
[TBL] [Abstract][Full Text] [Related]
4. Adrenocortical tumorigenesis in transgenic mice: the role of luteinizing hormone receptor and transcription factors GATA-4 and GATA-61.
Rahman NA; Kiiveri S; Siltanen S; Levallet J; Kero J; Lensu T; Wilson DB; Heikinheimo MT; Huhtaniemi IT
Reprod Biol; 2001 Jul; 1(1):5-9. PubMed ID: 14666170
[TBL] [Abstract][Full Text] [Related]
5. Use of hecate-chorionic gonadotropin beta conjugate in therapy of lutenizing hormone receptor expressing gonadal somatic cell tumors.
Rivero-Müller A; Vuorenoja S; Tuominen M; Wacławik A; Brokken LJ; Ziecik AJ; Huhtaniemi I; Rahman NA
Mol Cell Endocrinol; 2007 Apr; 269(1-2):17-25. PubMed ID: 17363137
[TBL] [Abstract][Full Text] [Related]
6. High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene.
Mikola M; Kero J; Nilson JH; Keri RA; Poutanen M; Huhtaniemi I
Oncogene; 2003 May; 22(21):3269-78. PubMed ID: 12761497
[TBL] [Abstract][Full Text] [Related]
7. Adrenocortical tumorigenesis, luteinizing hormone receptor and transcription factors GATA-4 and GATA-6.
Vuorenoja S; Rivero-Muller A; Kiiveri S; Bielinska M; Heikinheimo M; Wilson DB; Huhtaniemi IT; Rahman NA
Mol Cell Endocrinol; 2007 Apr; 269(1-2):38-45. PubMed ID: 17337116
[TBL] [Abstract][Full Text] [Related]
8. Growth repression in diethylstilbestrol/dimethylbenz[a]anthracene-induced rat mammary gland tumor using Hecate-CGbeta conjugate.
Zaleska M; Waclawik A; Bodek G; Zezula-Szpyra A; Li X; Janowski T; Hansel WH; Rahman NA; Ziecik AJ
Exp Biol Med (Maywood); 2004 Apr; 229(4):335-44. PubMed ID: 15044717
[TBL] [Abstract][Full Text] [Related]
9. A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate.
Bodek G; Rahman NA; Zaleska M; Soliymani R; Lankinen H; Hansel W; Huhtaniemi I; Ziecik AJ
Breast Cancer Res Treat; 2003 May; 79(1):1-10. PubMed ID: 12779076
[TBL] [Abstract][Full Text] [Related]
10. Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo.
Gawronska B; Leuschner C; Enright FM; Hansel W
Gynecol Oncol; 2002 Apr; 85(1):45-52. PubMed ID: 11925119
[TBL] [Abstract][Full Text] [Related]
11. Adrenocortical tumorigenesis in transgenic mice expressing the inhibin alpha-subunit promoter/simian virus 40 T-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4.
Rahman NA; Kiiveri S; Rivero-Müller A; Levallet J; Vierre S; Kero J; Wilson DB; Heikinheimo M; Huhtaniemi I
Mol Endocrinol; 2004 Oct; 18(10):2553-69. PubMed ID: 15256532
[TBL] [Abstract][Full Text] [Related]
12. Targeted destruction of normal and cancer cells through lutropin/choriogonadotropin receptors using Hecate-betaCG conjugate.
Zaleska M; Bodek G; Jana B; Hansel W; Ziecik AJ
Exp Clin Endocrinol Diabetes; 2003 May; 111(3):146-53. PubMed ID: 12784188
[TBL] [Abstract][Full Text] [Related]
13. Targeting breast and prostate cancers through their hormone receptors.
Leuschner C; Hansel W
Biol Reprod; 2005 Nov; 73(5):860-5. PubMed ID: 16033998
[TBL] [Abstract][Full Text] [Related]
14. Targeted ablation of prostate carcinoma cells through LH receptor using Hecate-CGbeta conjugate: functional characteristic and molecular mechanism of cell death pathway.
Bodek G; Kowalczyk A; Waclawik A; Huhtaniemi I; Ziecik AJ
Exp Biol Med (Maywood); 2005 Jun; 230(6):421-8. PubMed ID: 15956772
[TBL] [Abstract][Full Text] [Related]
15. Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors.
Leuschner C; Enright FM; Gawronska-Kozak B; Hansel W
Prostate; 2003 Sep; 56(4):239-49. PubMed ID: 12858351
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice expressing inhibin α-subunit promoter (inhα)/Simian Virus 40 T-antigen (Tag) transgene as a model for the therapy of granulosa cell-derived ovarian cancer.
Chrusciel M; Doroszko M; Stelmaszewska J; Li X; Ziecik AJ; Coelingh-Bennink HJ; Huhtaniemi I; Rahman NA
Reprod Biol; 2014 Mar; 14(1):25-31. PubMed ID: 24607252
[TBL] [Abstract][Full Text] [Related]
17. Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene.
Rilianawati ; Paukku T; Kero J; Zhang FP; Rahman N; Kananen K; Huhtaniemi I
Mol Endocrinol; 1998 Jun; 12(6):801-9. PubMed ID: 9626655
[TBL] [Abstract][Full Text] [Related]
18. Mouse strain susceptibility to gonadectomy-induced adrenocortical tumor formation correlates with the expression of GATA-4 and luteinizing hormone receptor.
Bielinska M; Parviainen H; Porter-Tinge SB; Kiiveri S; Genova E; Rahman N; Huhtaniemi IT; Muglia LJ; Heikinheimo M; Wilson DB
Endocrinology; 2003 Sep; 144(9):4123-33. PubMed ID: 12933687
[TBL] [Abstract][Full Text] [Related]
19. Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo.
Leuschner C; Enright FM; Gawronska B; Hansel W
Breast Cancer Res Treat; 2003 Mar; 78(1):17-27. PubMed ID: 12611453
[TBL] [Abstract][Full Text] [Related]
20. Targeted destruction of prostate cancer cells and xenografts by lytic peptide-betaLH conjugates.
Hansel W; Leuschner C; Gawrońska B; Enright F
Reprod Biol; 2001 Jul; 1(1):20-32. PubMed ID: 14666172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
